Page 3 - Hong Kong (HSI) Growth Pharmaceuticals & Biotech Stocks

UPDATED Apr 25, 2024

Discover Hong Kong Pharmaceuticals & Biotech Growth Stocks that are on the HSI. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.

100 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

2162

Keymed Biosciences
HK$34.9027.1%-44.2%HK$9.7bHK$58.98PS25.2xE-8.9%n/a

1672

Ascletis Pharma
HK$1.344.7%-47.2%HK$1.4bHK$2.98PS22.2xE-9.3%n/a

8049

Jilin Province Huinan Changlong Bio-pharmacy
HK$1.57-12.8%-3.1%HK$879.6mn/aPE5.5xn/a34.4%

1889

Sanai Health Industry Group
HK$0.026-7.1%-67.5%HK$99.4mn/aPE4.9xn/a0%

6622

Zhaoke Ophthalmology
HK$1.51-2.6%-59.5%HK$824.7mHK$7.69PS40.7xS85.8%n/a

1558

YiChang HEC ChangJiang Pharmaceutical
HK$12.803.6%81.0%HK$11.3bHK$14.00PE5.2xS2.2%0%

1498

PuraPharm
HK$0.750%-30.6%HK$296.3mn/aPB1.9xn/a0%

2161

JBM (Healthcare)
HK$0.88-3.3%-18.5%HK$728.3mn/aPE7.4xn/a7.8%

2157

Lepu Biopharma
HK$5.0416.9%-6.3%HK$8.4bHK$3.70PS34.4xS11.0%n/a

2257

Sirnaomics
HK$6.308.6%-88.6%HK$546.9mHK$72.19PS1746.6xS58.2%n/a

1061

Essex Bio-Technology
HK$2.19-5.2%-40.0%HK$1.2bn/aPE4.5xn/a4.1%

575

Regent Pacific Group
HK$0.40-5.9%-62.3%HK$91.4mn/aPS40.1xn/an/a

719

Shandong Xinhua Pharmaceutical
HK$5.453.8%-20.4%HK$9.3bn/aPE7.1xn/a5.0%

1643

Modern Chinese Medicine Group
HK$0.30-6.3%-37.5%HK$180.0mn/aPE3.4xn/a0%

2496

Wuhan YZY Biopharma
HK$7.450%n/aHK$1.4bn/aPS111.7xn/an/a

239

Pak Fah Yeow International
HK$2.123.4%46.2%HK$660.7mn/aPE6.3xn/a9.7%

2348

Dawnrays Pharmaceutical (Holdings)
HK$1.171.7%-12.7%HK$1.8bn/aPE5xn/a6.8%

6955

Shandong Boan Biotechnology
HK$10.000.8%-40.0%HK$5.1bHK$11.30PS7.6xS27.8%n/a

8158

China Regenerative Medicine International
HK$0.27-3.6%-74.8%HK$82.1mn/aPS1.2xn/an/a

1873

Viva Biotech Holdings
HK$0.5634.9%-65.2%HK$1.2bn/aPB0.3xn/an/a

2633

Jacobson Pharma
HK$0.56-1.8%-41.1%HK$1.1bn/aPE4.6xn/a8.7%

6660

AIM Vaccine
HK$8.250%-81.0%HK$10.0bHK$53.03PS7.8xS56.4%n/a

1349

Shanghai Fudan-Zhangjiang Bio-PharmaceuticalLtd
HK$2.174.3%-31.8%HK$6.4bn/aPE19.2xn/a3.5%

2197

Clover Biopharmaceuticals
HK$0.3610.8%-80.5%HK$466.9mn/aPS11xn/an/a
Page 3 of 5
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.